BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV

Clinical trial NCT02244021 · COMPLETED

Trial details

NCT number: NCT02244021
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Hodgkin's Lymphoma

Start date: 2014-12-01
Primary completion: 2016-07-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.